IG
VIVE

ING Group’s VIVEVE MED INC VIVE Stock Holding History

ING Group’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-432
Closed -$1.58M – 872
2018
Q1 		$1.58M Buy
432
+82
+23% +$357K 0.03% 244
2017
Q4 		$1.74M Buy
350
+25
+8% +$130K 0.03% 249
2017
Q3 		$1.7M Buy
325
+157
+93% +$968K 0.03% 243
2017
Q2 		$1.21M Buy
+168
New +$1.25M 0.02% 288

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

ING Group's VIVE Position: Q2 2018 in Review

ING Group sold out of VIVEVE MED INC (VIVE) in Q2 2018, closing a stake of 432 shares — an estimated $1.58M sold.

ING Group first reported a position in VIVE in Q2 2017 and held it in 4 quarters. The position peaked at $1.74M in Q4 2017. 46 funds tracked by Wall St. Rank hold VIVE as of Q2 2018.

  • ING Group reported no remaining VIVEVE MED INC position as of Q2 2018 after selling out during the quarter.
  • ING Group sold 432 VIVEVE MED INC shares in Q2 2018, an estimated $1.58M.
  • ING Group first reported a position in VIVEVE MED INC in Q2 2017 and held it in 4 quarters.
  • ING Group's VIVEVE MED INC position peaked at $1.74M in Q4 2017.
  • 46 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2018.

Based on ING Group's 13F filing for Q2 2018, filed 10 Aug 2018.